Octreotide Acetate
NDC 68083-517, Octreotide Acetate, injection, solution, from Gland Pharma Limited.
- Product NDC
- 68083-517
- Status
- Listed
- Labeler
- Gland Pharma Limited
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216839
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68083-517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OCTREOTIDE ACETATE100 ug/mL
Pharmacologic classes
Somatostatin Analog [EPC]; Somatostatin Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68083-517-10 | 68083051710 | 10 VIAL in 1 CARTON (68083-517-10) / 1 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/884e4287-a4d8-4a6e-8d99-dbe5e88875b9
Use it
Look up 68083-517 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68083-517 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68083-517. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.